Both in Pharmaceuticals
Acrivon Therapeutics vs Medicinova
Over the past year ACRV returned −19.1% and MNOV returned +2.1%; their daily moves had a correlation of -0.02.
ACRV −19.1% MNOV +2.1%Growth of $1, one year, split-adjusted
| Metric | ACRV | MNOV |
|---|---|---|
| Price | $1.74 | $1.45 |
| Market cap | $74.6M | $71.4M |
| Today | +4.19% | +2.11% |
| 1 month | −6.5% | −12.1% |
| 6 months | −16.7% | 0.0% |
| Year to date | −27.8% | +10.7% |
| 1 year | −25.3% | −3.3% |
| Revenue growth (YoY) | — | +240.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −504.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 77.5× |
| Net cash | $90.0M | $25.4M |
| Dividend yield | — | — |
| Volatility (60d) | 71.1% | 114.6% |
| Short % of float | 7.2% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).